Newer contrast agents safe for childrenJune 08, 2007Allergic-like reactions to newer iodine-containing contrast agents (nonionic contrast media), are rare in children according to a recent study conducted by researchers from the University of Michigan Medical Center and C.S. Mott Children's Hospital both in Ann Arbor. "A major, if not the main, risk associated with iodine-containing contrast agents is allergic types of reactions. Such reactions can be mild; for example, hives or severe such as difficulty breathing or even cardiopulmonary arrest," said Jonathan R. Dillman, MD, lead author of the study. "Over the past 20 years, we have changed the type of iodine-containing intravenous contrast agents used primarily for computed tomography (CT) and intravenous pyelogram (IVP) examinations in both adult and pediatric patients. The nonionic contrast media that we now use have been studied extensively in adults, but not as much in children. We performed our study because we wanted to find out what the exact risk of allergic reactions to these newer contrast agents was in children," said Dr. Dillman.
The study evaluated 11,306 pediatric IV administrations of iodine-containing contrast agents over a seven year period. According to the study, acute allergic-like reactions were documented in 20 of the patients. Of these patients, 16 of the allergic-like reactions were categorized as mild, one as moderate, and three as severe. Six of the reacting patients had a history of allergic-like reactions, including two patients who had a history of reactions to iodinated contrast material. Five of the patients had a history of asthma. "While we have long assumed that newer nonionic contrast agents are safe, this study re-affirms their safety and better determines what the risks actually are in children," said Richard H. Cohan, MD, co-author of the study. "Our study confirms that doctors and parents alike can feel comfortable administering these agents to children," he said. The full results of this study appear in the June issue of the American Journal of Roentgenology, published by the American Roentgen Ray Society. American Roentgen Ray Society | |||||||||||||||||||||
|
Related Contrast Agents Current Events and Contrast Agents News Articles Late-breaking results of clinical trial on therapeutic endovascular cooling reported at TCT 2008 Late-breaking results from the COOL RCN (COOLing to Prevent Radio Contrast Nephropathy in Patients Undergoing Diagnostic or Interventional Catheterization) Trial were presented during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). New technique sees into tissue at greater depth, resolution By coupling a kicked-up version of microscopy with miniscule particles of gold, Duke University scientists are now able to peer so deep into living tissue that they can see molecules interacting. A new 'Pyrex' nanoparticle Researchers in Switzerland have developed a new method to fabricate borosilicate glass nanoparticles. Used in microfluidic systems, these "Pyrex"-like nanoparticles are more stable when subjected to temperature fluctuations and harsh chemical environments than currently used nanoparticles made of polymers or silica glass. Tiny 3-D ultrasound probe guides catheter procedures An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance. Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize - with "exquisite" specificity - cell populations of interest in the living body. New disease-fighting nanoparticles look like miniature pastries Ultra-miniature bialy-shaped particles - called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City - could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques. Brown Chemists Create Cancer-Detecting Nanoparticles A team led by a Brown University chemist has created the smallest iron oxide nanoparticles to date for cancer detection by magnetic resonance imaging (MRI). The magnetic nanoparticles operate like tiny guided missiles, seeking and attaching themselves to malignant tumor cells. Once they bind, the particles emit stronger signals that MRI scans can detect. MRI better than MDCT in detecting endoleaks, study says Contrast-enhanced MR imaging is significantly superior to 16 slice multidetector CT in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study conducted by researchers at Ospedale San Giovanni in Bellinzona, Switzerland. New Research Shows Benefits of Ultrasound Contrast Agents Outweigh Potential Risk to Heart Patients ST. LOUIS - A Saint Louis University cardiologist called upon the U.S. Food and Drug Administration (FDA) on Monday to reconsider a strong warning it recently placed on a diagnostic tool, stating that the warning could prevent doctors from detecting life-threatening cardiac events. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients A combined therapeutic approach of stenting and photodynamic therapy may improve survival rates for patients suffering from advanced liver bile duct cancer, according to a study published this month in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. More Contrast Agents Current Events and Contrast Agents News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||